Sub-MIC of antibiotics induced biofilm formation of Pseudomonas aeruginosa in the presence of chlorhexidine

Brazilian Journal of Microbiology

Volumn 46, Issue 1, 2015, Pages 149-154

  Aka, Safaa T ^a   Haji, Sayran H ^a  

^a HAWLER MEDICAL UNIVERSITY   (Iraq)

Author keywords

Antibiotic; Biofilm; Chlorhexidine; P. aeruginosa; Sub MIC

Indexed keywords

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ANTIINFECTIVE AGENT; CHLORHEXIDINE; GROWTH PROMOTOR;

BIOFILM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BIOFILMS; CHLORHEXIDINE; GROWTH SUBSTANCES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 84930443514     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-838246120140218     Document Type: Article

References (31)

1. Araújo P, Lemos M, Mergulhão F et al. (2011) Antimicrobial resistance to disinfectants in biofilms. In: A. Méndez-Vilas (ed) Science Against Microbial Pathogens: Communicating Current Research and Technological Advances. Formatex, Badajoz, pp 826-834.
2. Bagge N, Schuster M, Hentzer M et al. (2004) Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and -lactamase and alginate production. Antimicrob Agents Chemotherapy 48:1175-1187.
3. Boehm A, Steiner S, Zaehringer F et al. (2009) Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol Microbiol 72:1500-1516.
4. Borriello G, Werner E, Roe F et al. (2004) Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 48:2659-2664.
5. Braoudaki M, Hilton AC (2004) Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157. FEMS Microbiol Lett 235:305-309.
6. Chapman JS (2003) Biocide resistance mechanisms. Int Biodeterior Biodegradation 51:133-138.
7. Costerton J, Lewandowski Z, DeBeer D et al. (1994) Biofilms, the customized microniche. J Bacteriol 176:2137.
8. Denyer SP, Stewart G (1998) Mechanisms of action of disinfectants. International Biodeterioration and Biodegradation 41:261-268.
9. Fux C, Costerton J, Stewart P et al. (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34-40.
10. Gilbert P, Allison D, McBain A (2002) Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? J Appl Microbiol 92:98S-110S.
11. Gillis RJ, Iglewski BH (2004) Azithromycin retards Pseudomonas aeruginosa biofilm formation. J Clin Microbiol 42:5842-5845.
12. Hoffman LR, D’Argenio DA, MacCoss MJ et al. (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436:1171-1175.
13. Kaplan JB (2011) Antibiotic-induced biofilm formation. Int J Artif Organs 34:737-751.
14. Kaplan JB, Jabbouri S, Sadovskaya I (2011) Extracellular DNAdependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics. Res Microbiol 162:535-541.
15. Linares J, Gustafsson I, Baquero F et al. (2006) Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci 103:19484-19489.
16. Mah T-FC, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34-39.
17. Masadeh MM, Mhaidat NM, Alzoubi KH et al. (2012) In vitro determination of the antibiotic susceptibility of biofilmforming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide. Infect Drug Res 6:27-32.
18. McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147-179.
19. Nagino K, Kobayashi H (1997) Influence of macrolides on mucoid alginate biosynthetic enzyme from Pseudomonas aeruginosa. Clin Microbiol Infect 3:432-439.
20. Oz Y, Dag I, Kiraz N (2012) Efficacy of Disinfectants on Candida Biofilms at Different Concentrations and Contact Times. B M Research Journal 2:40-52.
21. Poole K (2004) Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 10:12-26.
22. Potera C (1999) Forging a link between biofilms and disease. Science 283:1837-1839.
23. Russell A (2003) Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 3:794-803.
24. Sailer FC, Meberg BM, Young KD (2003) -Lactam induction of colanic acid gene expression in Escherichia coli. FEMS Microbiol Lett 226:245-249.
25. Saiman L, Marshall BC, Mayer-Hamblett N et al. (2003) Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290:1749-1756.
26. Simões M, Pereira MO, Vieira MJ (2005) Action of a cationic surfactant on the activity and removal of bacterial biofilms formed under different flow regimes. Water Res 39:478-486.
27. Smith K, Hunter IS (2008) Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. J Med Microbiol 57:966-973.
28. Vincent J-L (2003) Nosocomial infections in adult intensive-care units. Lancet 361:2068-2077.
29. Wagner T, Soong G, Sokol S et al. (2005) Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. CHEST J 128:912-919.
30. Yildiz FH (2008) Cyclic dimeric GMP signaling and regulation of surface-associated developmental programs. J Bacteriol 190:781-783.
31. Zhang L, Mah T-F (2008) Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190:4447-4452.